Schizophrenia: open trials in Hungary

• 2024-519836-18-00

  Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics

  Trial Treatment · Phase 3 · Newron Pharmaceuticals S.p.A.

  Semmelweis University, Budapest · Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr · Szabolcs Szatmár Bereg Vármegyei Oktatókórház, Nyíregyháza · Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz, Szombathely

  Registry updated 2026-11-04

• NCT06585787

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  Semmelweis University, Budapest · Eszak-Budai Szent Janos Centrumkorhaz, Budapest XII · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Psychotech Kft., Pécs

  Registry updated 2026-10-27

• NCT07424404

  A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  Budapest · Gyula · Szeged

  Registry updated 2026-10-15

• NCT06887192

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  Trial Treatment · Phase 2 · MapLight Therapeutics

  Gyöngyösi Bugát Pál Kórház, Gyongyos · Psychotech Kft., Pécs · University of Pecs, Pécs

  Registry updated 2026-09-30

• NCT07105098

  NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  Trial Treatment · Phase 3 · Neurocrine Biosciences

  Semmelweis University, Budapest · Gyoengyosi Bugat Pal Koerhaz, Gyongyos · Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr

  Registry updated 2026-09-25

• NCT07114874

  NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  Trial Treatment · Phase 3 · Neurocrine Biosciences

  Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Gyoengyosi Bugat Pal Koerhaz, Gyongyos

  Registry updated 2026-09-25

• NCT07459660

  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  Trial Treatment · Phase 2 · MapLight Therapeutics

  Gyöngyösi Bugát Pál Kórház, Gyongyos · Psychotech Kft., Pécs · University of Pecs, Pécs

  Registry updated 2026-08-07

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error